Another previous study showed that increased VEGF mRNA expression in plasma and tumor stroma was associated with resistance to EGFR-TKIs, and combined EGFR-TKIs and VEGF inhibitors had synergistic antitumor effects in an NSCLC mouse model (11). Here, EGFR is linked to non-small cell lung carcinoma.